| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-27 | FY 2024
FILED 2024-12-28 | FY 2023
FILED 2023-12-30 |
|---|---|---|---|
| Revenue (Total Sales) | $24.94B | $25.85B | $12.80B |
| YoY Revenue Growth % | — | — | — |
| Gross Profit | $8.31B | $8.97B | $0 |
| Gross Margin % | 33.3% | 34.7% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$4.67B | $1.68B | $4.57B |
| Operating Margin % | -18.7% | 6.5% | — |
| Net Income (GAAP) | -$5.85B | $2.74B | $2.85B |
| EBITDA (Normalized) | -$4.03B | $2.50B | $4.57B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $4.46B | $4.18B | $3.98B |
| Capital Expenditures (CapEx) | $801.0M | $1.02B | $0 |
| Free Cash Flow (FCF) | $3.66B | $3.16B | $3.98B |
| FCF Margin % | 14.7% | 12.2% | — |
| Return on Invested Capital (ROIC %) | -6.5% | 2.0% | 38.4% |
| Cash & Short-Term Equivalents | $2.62B | $1.33B | — |
| Total Debt (Short + Long Term) | $18.00B | $17.53B | $3.65B |
| Total Stockholders' Equity | $41.66B | $49.19B | $7.48B |